Literature DB >> 32150612

Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines.

Itziar Etxeandia-Ikobaltzeta1, Yuan Zhang1, Francesca Brundisini1, Ivan D Florez1,2, Wojtek Wiercioch1, Robby Nieuwlaat1, Housne Begum1, Carlos A Cuello1,3, Yetiani Roldan1, Ru Chen4, Chengyi Ding5, Rebecca L Morgan1, John J Riva1,6, Yuqing Zhang1, Rana Charide7, Arnav Agarwal8, Sara Balduzzi9, Gian Paolo Morgano1, Juan José Yepes-Nuñez10, Yasir Rehman1, Ignacio Neumann11, Nicole Schwab12, Tejan Baldeh1, Cody Braun13, María Francisca Rodríguez14, Holger J Schünemann1,15.   

Abstract

Values and preferences relate to the importance that patients place on health outcomes (eg, bleeding, having a deep venous thrombosis) and are essential when weighing benefits and harms in guideline recommendations. To inform the American Society of Hematology guidelines for management of venous thromboembolism (VTE) disease, we conducted a systematic review of patients' values and preferences related to VTE. We searched Medline, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature from inception to April of 2018 (PROSPERO-CRD42018094003). We included quantitative and qualitative studies. We followed Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidance for rating the certainty and presenting findings for quantitative research about the relative importance of health outcomes and a grounded theory approach for qualitative thematic synthesis. We identified 14 quantitative studies (2465 participants) describing the relative importance of VTE-related health states in a widely diverse population of patients, showing overall small to important impact on patients' lives (certainty of the evidence from low to moderate). Additionally, evidence from 34 quantitative studies (6424 participants) and 15 qualitative studies (570 participants) revealed that patients put higher value on VTE risk reduction than on the potential harms of the treatment (certainty of evidence from low to moderate). Studies also suggested a clear preference for oral medication over subcutaneous medication (moderate certainty). The observed variability in health state values may be a result of differences in the approaches used to elicit them and the diversity of included populations rather than true variability in values. This finding highlights the necessity to explore the variability induced by different approaches to ascertain values.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32150612      PMCID: PMC7065473          DOI: 10.1182/bloodadvances.2019000462

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  85 in total

1.  Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy.

Authors:  David John Mott; Mehdi Najafzadeh
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-11-20       Impact factor: 2.217

2.  The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines.

Authors:  Victor M Montori; Juan Pablo Brito; M Hassan Murad
Journal:  JAMA       Date:  2013-12-18       Impact factor: 56.272

3.  The experiences and challenges of pregnant women coping with thrombophilia.

Authors:  Tanya Z Martens; Jessica D Emed
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2007 Jan-Feb

4.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

5.  Technology-assisted self-testing and management of oral anticoagulation therapy: a qualitative patient-focused study.

Authors:  Jasna Kuljis; Arthur G Money; Mark Perry; Julie Barnett; Terry Young
Journal:  Scand J Caring Sci       Date:  2016-08-08

6.  Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injury.

Authors:  Faye Y Chiou-Tan; Hector Garza; Kwai-Tung Chan; Kenneth C Parsons; William H Donovan; Claudia S Robertson; Sally Ann Holmes; Daniel E Graves; Diana H Rintala
Journal:  Am J Phys Med Rehabil       Date:  2003-09       Impact factor: 2.159

7.  Eliciting patients' preferences for elastic compression stocking therapy after deep vein thrombosis: potential for improving compliance.

Authors:  A C Bouman; A J Ten Cate-Hoek; C D Dirksen; M A Joore
Journal:  J Thromb Haemost       Date:  2016-02-05       Impact factor: 5.824

8.  Patient preferences for testing for pulmonary embolism in the ED using a shared decision-making model.

Authors:  Brian C Geyer; Maria Xu; Christopher Kabrhel
Journal:  Am J Emerg Med       Date:  2013-11-14       Impact factor: 2.469

9.  Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study.

Authors:  A M Robinson; K A McLean; M Greaves; K S Channer
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

Review 10.  Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.

Authors:  Yuan Zhang; Pablo Alonso Coello; Jan Brożek; Wojtek Wiercioch; Itziar Etxeandia-Ikobaltzeta; Elie A Akl; Joerg J Meerpohl; Waleed Alhazzani; Alonso Carrasco-Labra; Rebecca L Morgan; Reem A Mustafa; John J Riva; Ainsley Moore; Juan José Yepes-Nuñez; Carlos Cuello-Garcia; Zulfa AlRayees; Veena Manja; Maicon Falavigna; Ignacio Neumann; Romina Brignardello-Petersen; Nancy Santesso; Bram Rochwerg; Andrea Darzi; Maria Ximena Rojas; Yaser Adi; Claudia Bollig; Reem Waziry; Holger J Schünemann
Journal:  Health Qual Life Outcomes       Date:  2017-05-02       Impact factor: 3.186

View more
  7 in total

1.  A user guide to the American Society of Hematology clinical practice guidelines.

Authors:  Ariel Izcovich; Adam Cuker; Robert Kunkle; Ignacio Neumann; Julie Panepinto; Menaka Pai; Matthew Seftel; Matthew C Cheung; Richard Lottenberg; Michael Byrne; Robert Plovnick; Deirdra Terrell; Jennifer L Holter-Chakrabarty; Benjamin Djulbegovic; Lisa K Hicks; Wojtek Wiercioch; Robby Nieuwlaat; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-05-12

2.  Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences.

Authors:  Wojtek Wiercioch; Robby Nieuwlaat; Elie A Akl; Robert Kunkle; Kendall E Alexander; Adam Cuker; Anita Rajasekhar; Pablo Alonso-Coello; David R Anderson; Shannon M Bates; Mary Cushman; Philipp Dahm; Gordon Guyatt; Alfonso Iorio; Wendy Lim; Gary H Lyman; Saskia Middeldorp; Paul Monagle; Reem A Mustafa; Ignacio Neumann; Thomas L Ortel; Bram Rochwerg; Nancy Santesso; Sara K Vesely; Daniel M Witt; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-05-26

3.  DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines.

Authors:  Ignacio Neumann; Ariel Izcovich; Yuqing Zhang; Gabriel Rada; Susan R Kahn; Frederick Spencer; Suely Rezende; Franchesco Dentali; Kenneth Bauer; Gian Paolo Morgano; Juan J Yepes-Nuñez; Robby Nieuwlaat; Wojtek Wiercioch; Liming Lu; Jiaming Wu; Mary Cushman; Holger Schunemann
Journal:  Blood Adv       Date:  2020-04-14

Review 4.  Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation.

Authors:  Anette Arbjerg Højen; Peter Brønnum Nielsen; Thure Filskov Overvad; Ida Ehlers Albertsen; Frederikus A Klok; Nanna Rolving; Mette Søgaard; Anne Gulbech Ording
Journal:  J Clin Med       Date:  2022-10-10       Impact factor: 4.964

5.  Association between VTE and antibiotic prophylaxis guideline compliance and patient-reported outcomes after total hip and knee arthroplasty: an observational study.

Authors:  Helen Badge; Tim Churches; Justine M Naylor; Wei Xuan; Elizabeth Armstrong; Leeanne Gray; John Fletcher; Iain Gosbell; Chung-Wei Christine Lin; Ian A Harris
Journal:  J Patient Rep Outcomes       Date:  2022-10-12

Review 6.  Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review.

Authors:  Montserrat León-García; Brittany Humphries; Andrea Maraboto; Montserrat Rabassa; Kasey R Boehmer; Lilisbeth Perestelo-Perez; Feng Xie; Irene Pelayo; Mark Eckman; Shannon Bates; Anna Selva; Pablo Alonso-Coello
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-05       Impact factor: 3.105

7.  Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists.

Authors:  Anette Arbjerg Højen; Thure Filskov Overvad; Mads Nybo; Thomas Kümler; Morten Schnack Rasmussen; Thomas Decker Christensen; Torben Bjerregaard Larsen
Journal:  TH Open       Date:  2021-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.